KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to $23.1 million.

  • Neogenomics' Accounts Payables rose 686.35% to $23.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $23.1 million, marking a year-over-year increase of 686.35%. This contributed to the annual value of $23.1 million for FY2025, which is 686.35% up from last year.
  • Per Neogenomics' latest filing, its Accounts Payables stood at $23.1 million for Q4 2025, which was up 686.35% from $22.6 million recorded in Q3 2025.
  • Neogenomics' 5-year Accounts Payables high stood at $28.5 million for Q3 2021, and its period low was $13.7 million during Q3 2022.
  • Its 5-year average for Accounts Payables is $20.0 million, with a median of $19.6 million in 2021.
  • As far as peak fluctuations go, Neogenomics' Accounts Payables surged by 6090.22% in 2021, and later tumbled by 5196.24% in 2022.
  • Over the past 5 years, Neogenomics' Accounts Payables (Quarter) stood at $17.9 million in 2021, then increased by 14.45% to $20.5 million in 2022, then fell by 0.86% to $20.3 million in 2023, then increased by 6.26% to $21.6 million in 2024, then increased by 6.86% to $23.1 million in 2025.
  • Its Accounts Payables was $23.1 million in Q4 2025, compared to $22.6 million in Q3 2025 and $27.5 million in Q2 2025.